Assuta Ashdod Public Hospital (R.A)

Ashdod 7747629

1 studies enrolling now · 4 studies all time

What they study most

Acute Non-cardioembolic Ischemic Stroke, Advanced Non-small Cell Lung Cancer, HER2 Mutation, Heart Failure, High-risk Transient Ischemic Attack, Non-diabetic Chronic Kidney Disease, Prevention of Ischemic Stroke

Studies at this site

• A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) — Recruiting now
• A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease — Completed
• A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke — Completed
• Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40% — Completed